Back to Search
ERIC HAURA, MD
MD
Medical Oncology Physician
NPI: 1801829007IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
ME82324(FL)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME82324(FL)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
DUKE UNIVERSITY SCHOOL OF MEDICINE
Class of 1994
Research & Publications (20)
Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer.
PMID 16512982·Clin Lung Cancer·2006
8-other
Is repetitive wounding and bone marrow-derived stem cell mediated-repair an etiology of lung cancer development and dissemination?
PMID 16714090·Med Hypotheses·2006
8-other
Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
PMID 16322287·Clin Cancer Res·2005
8-other
Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
PMID 16264989·Nat Clin Pract Oncol·2005
6-review
Antiapoptotic signaling pathways in non-small-cell lung cancer: biology and therapeutic strategies.
PMID 15476597·Clin Lung Cancer·2004
4-observational
Management of advanced non-small cell lung cancer: current trends.
PMID 12055385·Curr Opin Pulm Med·2002
6-review
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
PMID 19633423·Cancer Biol Ther·2009
7-preclinical
Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines.
PMID 18844224·Int J Cancer·2009
8-other
MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion.
PMID 19578748·Int J Oncol·2009
8-other
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
PMID 18827606·J Thorac Oncol·2008
3-trial
A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
PMID 17505826·Cancer Chemother Pharmacol·2008
8-other
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.
PMID 18300255·Cancer·2008
3-trial
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
PMID 18316570·Clin Cancer Res·2008
3-trial
IPEP: an in silico tool to examine proteolytic peptides for mass spectrometry.
PMID 18842605·Bioinformatics·2008
8-other
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
PMID 17602079·J Clin Oncol·2007
3-trial
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells.
PMID 17876048·Mol Cancer Ther·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR, MDC 44
TAMPA, FL 33612 - Phone
- (813) 745-3980
Quick Facts
- NPI
- 1801829007
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile